Polyunsaturated fatty acids (PUFAs) are necessary for overall health. The two PUFAs families, n-6 and n-3 fatty acid are physiologically and metabolically distinct. Proportion of PUFAs in serum and erythrocyte phospholipids is an important determinant of both health and disease, and depends on endogenous metabolism controlled by genetic polymorphisms and dietary intake. Both n-3 and n-6 PUFAs are processed to powerful promoters of eicosanoids synthesis at the cyclooxygenase and lipoxygenase level. Evidence from observational and intervention studies suggest that n-3 PUFAs are cardioprotective, perhaps through their anti-inflammatory, anti-arrhythmic, lipid-lowering, and antihypertensive effects. In contrast, dietary n-6 PUFAs have pro-inflammatory effect. Low n-3 and elevated n-6 PUFAs levels were found in patients with cancer on different sites. The present review will focus on the current knowledge related to PUFAs intake and status in health and disease, with reference to the Serbian population. [Projekat Ministarstva nauke Republike Srbije, br. III41030
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.